US Stimulus Talks Make Progress

Expectations are growing for US lawmakers to reach a bipartisan relief bill this month and as immunization plans are unveiled across the UK and US. A second COVID relief bill appears likely now that Democrats have returned to the negotiating table with a much lower starting point. US stocks turned positive after news that House Speaker Pelosi and Senator Schumer supported the USD908 billion stimulus plan as a base for negotiations.

After the US close, the House gave its approval on the bill that will restrict Chinese firms from listing in the US. This legislation has been in the works for several months and will force Chinese firms to allow inspectors to review their books. Chinese technology stocks opened sharply lower, triggering profit-taking and not likely the beginning of a new trend.

In China, the data continues to impress, as the reading rose to 57.8, exceeding the consensus estimate of 56.4 and the prior 56.8 reading. China PMIs remain well into expansionary territory in both the services and manufacturing sectors. The Asian giant has been the bright spot of the global economic recovery and should continue to lead the way, despite the US regulatory crackdown.

On the employment front, in November rose 307,000, less than the consensus estimate of 430,000 and lower than the revised prior reading of 404,000. The ADP survey was taken after a jump in weekly initial unemployment claims, so even though the private report has recently under-delivered job hiring compared to the report, Friday’s main event could provide a soft reading. The official nonfarm payroll report, always a key event, is projected to slow for a fifth consecutive month, with a forecast of 500 thousand. The previous reading was 638 thousand. Wage growth is expected to remain steady at 0.1%.

Original Post

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.